Anika Therapeutics Stock Price History

ANIK Stock  USD 15.62  0.33  2.07%   
Below is the normalized historical share price chart for Anika Therapeutics extending back to May 03, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Anika Therapeutics stands at 15.62, as last reported on the 20th of March, with the highest price reaching 15.85 and the lowest price hitting 15.52 during the day.
IPO Date
29th of April 1993
200 Day MA
21.6307
50 Day MA
16.8646
Beta
0.95
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Anika Stock, it is important to understand the factors that can impact its price. Anika Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0231, which signifies that the company had a -0.0231 % return per unit of risk over the last 3 months. Anika Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Anika Therapeutics' Risk Adjusted Performance of (0.06), mean deviation of 1.46, and Standard Deviation of 2.12 to double-check the risk estimate we provide.
  
Capital Stock is expected to rise to about 158.6 K this year, although the value of Total Stockholder Equity will most likely fall to about 122.4 M. . At this time, Anika Therapeutics' Price Fair Value is quite stable compared to the past year. Anika Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0231

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsANIK

Estimated Market Risk

 2.13
  actual daily
19
81% of assets are more volatile

Expected Return

 -0.05
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Anika Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Anika Therapeutics by adding Anika Therapeutics to a well-diversified portfolio.
Price Book
1.46
Enterprise Value Ebitda
64.614
Price Sales
1.8857
Shares Float
10.4 M
Wall Street Target Price
24

Anika Therapeutics Stock Price History Chart

There are several ways to analyze Anika Stock price data. The simplest method is using a basic Anika candlestick price chart, which shows Anika Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceFebruary 5, 202517.97
Lowest PriceMarch 13, 202515.21

Anika Therapeutics March 20, 2025 Stock Price Synopsis

Various analyses of Anika Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Anika Stock. It can be used to describe the percentage change in the price of Anika Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Anika Stock.
Anika Therapeutics Accumulation Distribution 1,230 
Anika Therapeutics Price Daily Balance Of Power(1.00)
Anika Therapeutics Price Rate Of Daily Change 0.98 
Anika Therapeutics Price Action Indicator(0.23)

Anika Therapeutics March 20, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Anika Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Anika Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Anika Stock and then apply it to test your longer-term investment strategies against Anika.

Anika Stock Price History Data

The price series of Anika Therapeutics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 2.76 with a coefficient of variation of 4.36. The prices are distributed with arithmetic mean of 16.79. The median price for the last 90 days is 16.74.
OpenHighLowCloseVolume
03/20/2025 15.95  15.85  15.52  15.62  59,088 
03/19/2025 15.93  16.10  15.62  15.95  77,888 
03/18/2025 16.19  16.45  15.54  15.86  87,981 
03/17/2025 15.99  16.70  15.63  16.11  65,782 
03/14/2025 15.29  15.97  14.97  15.91  98,661 
03/13/2025 16.41  17.10  14.95  15.21  158,575 
03/12/2025 16.69  17.14  16.27  17.11  113,996 
03/11/2025 16.51  16.83  16.35  16.79  113,339 
03/10/2025 16.60  17.00  16.46  16.50  102,918 
03/07/2025 17.21  17.21  16.47  16.62  97,750 
03/06/2025 16.89  17.35  16.83  17.00  145,472 
03/05/2025 16.75  17.13  16.75  17.03  55,877 
03/04/2025 17.12  17.56  16.86  16.86  101,666 
03/03/2025 17.45  17.61  17.09  17.20  52,984 
02/28/2025 17.69  17.74  17.33  17.45  59,376 
02/27/2025 17.61  17.74  16.98  17.67  37,238 
02/26/2025 17.63  17.94  17.44  17.69  65,838 
02/25/2025 17.48  18.00  17.33  17.71  89,421 
02/24/2025 17.95  18.07  17.32  17.43  83,983 
02/21/2025 17.75  17.81  17.39  17.39  51,660 
02/20/2025 17.71  18.19  17.59  17.65  47,589 
02/19/2025 17.66  17.95  17.44  17.82  37,716 
02/18/2025 17.75  18.35  17.63  17.75  63,291 
02/14/2025 17.75  17.90  17.62  17.86  33,046 
02/13/2025 17.68  17.68  17.28  17.65  67,240 
02/12/2025 17.52  17.93  17.52  17.61  73,302 
02/11/2025 17.53  17.94  17.42  17.76  58,167 
02/10/2025 17.81  17.81  17.54  17.71  57,889 
02/07/2025 17.70  18.01  17.61  17.79  97,728 
02/06/2025 17.96  18.11  17.77  17.79  51,698 
02/05/2025 17.75  18.37  17.61  17.97  113,382 
02/04/2025 17.11  17.85  17.11  17.84  45,548 
02/03/2025 16.88  17.32  16.71  17.28  45,437 
01/31/2025 17.36  17.62  16.98  17.06  80,274 
01/30/2025 16.97  17.41  16.97  17.28  39,488 
01/29/2025 16.68  17.17  16.65  16.93  44,294 
01/28/2025 16.63  16.98  16.20  16.74  66,584 
01/27/2025 16.20  16.82  16.19  16.71  50,473 
01/24/2025 16.30  16.48  15.93  16.31  48,181 
01/23/2025 16.19  16.37  15.99  16.37  51,104 
01/22/2025 16.44  16.68  16.22  16.22  50,739 
01/21/2025 16.20  17.00  16.20  16.50  57,718 
01/17/2025 16.21  17.22  16.01  16.07  64,552 
01/16/2025 15.96  16.27  15.80  16.19  58,748 
01/15/2025 15.85  16.10  15.66  16.02  56,776 
01/14/2025 16.03  16.03  15.49  15.58  52,894 
01/13/2025 15.45  15.96  15.40  15.92  76,484 
01/10/2025 15.88  15.90  15.46  15.57  98,928 
01/08/2025 15.57  16.22  15.48  15.94  82,459 
01/07/2025 15.85  16.15  15.60  15.70  89,077 
01/06/2025 16.16  16.92  15.88  15.91  62,466 
01/03/2025 16.22  16.46  16.07  16.19  48,589 
01/02/2025 16.58  16.69  16.19  16.21  66,511 
12/31/2024 16.37  16.54  16.10  16.46  62,503 
12/30/2024 16.15  16.46  15.90  16.25  57,994 
12/27/2024 16.49  16.52  16.03  16.24  74,508 
12/26/2024 16.26  16.73  16.18  16.65  49,440 
12/24/2024 16.48  16.68  16.25  16.33  48,954 
12/23/2024 16.25  16.56  15.85  16.23  61,902 
12/20/2024 16.15  17.04  15.96  16.31  215,721 
12/19/2024 15.99  16.44  15.88  16.33  87,300 

About Anika Therapeutics Stock history

Anika Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Anika is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Anika Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Anika Therapeutics stock prices may prove useful in developing a viable investing in Anika Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding14.7 M12.8 M
Net Loss-17.1 M-16.2 M

Anika Therapeutics Quarterly Net Working Capital

90.35 Million

Anika Therapeutics Stock Technical Analysis

Anika Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Anika Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Anika Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

Anika Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Anika Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Anika Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Anika to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Anika Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Anika Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Anika Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Anika Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anika Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.51)
Earnings Share
(0.60)
Revenue Per Share
8.145
Quarterly Revenue Growth
(0.29)
Return On Assets
(0.01)
The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.